Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
KLAC$130.53-19.12(-12.78%)KLA Declares Regular Cash Dividend4:30:14 PM ETMU$665.03-130.43(-16.40%)Micron Announces Board of Directors Retirement4:30:06 PM ETMU$665.03-130.43(-16.40%)Micron Announces Board of Directors Retirement4:30:00 PM ETKO$95.78-0.10(-0.10%)DRIVX Moves Toward Final Presale Stage, Unveils Fleet Expansion and Transparent Vesting Strategy4:19:08 PM ETCRWD$218.60-22.38(-9.29%)Why CrowdStrike and cybersecurity stocks got crunched in Thursday's rout4:12:00 PM ETNVDA$182.50-17.79(-8.88%)Nvidia's Huang is asked to brief Congress on reported Chinese spy relationship4:09:56 PM ETLRCX$191.05-30.23(-13.66%)Lam Research Corporation Announces $25 Billion Share Repurchase Authorization and Declares Quarterly Dividend4:05:00 PM ETSKHY$124.32-18.76(-13.11%)Why SK Hynix Plunged Today4:01:39 PM ETNVDA$182.50-17.79(-8.88%)Is Nvidia Still a Millionaire-Maker Stock?3:51:00 PM ETTSLA$341.91-43.27(-11.23%)SpaceX and Tesla Stock Plunges Have Wiped About $450 Billion in Value Since the Midterms. Is It Time to Buy?3:43:35 PM ETGOOGL$280.14-8.89(-3.08%)Google plans $17 billion Wyoming data center amid rising threats of curbs3:43:13 PM ETNOW$101.21-7.70(-7.07%)Arista Networks vs. ServiceNow: Which Technology Stock Is a Better Buy for 2027?3:43:02 PM ETGOOGL$280.14-8.89(-3.08%)BREAKINGVIEWS-Global muscle will sift puny data center providers3:30:09 PM ETAMD$408.18-80.51(-16.47%)Is AMD Stock a Buy as AI Revenue Soars?3:19:00 PM ETGEV$770.56-61.95(-7.44%)GE Vernova vs. NextEra Energy: Which Industrials Stock Is a Better Buy for 2027?3:17:11 PM ETBRK-A$857,487.54-9,063.79(-1.05%)Berkshire Hathaway Reports Nov. 7 With Its Stock at a Record. Its Cash Pile Is the Number to Watch.3:17:02 PM ETC$118.48+0.68(+0.58%)UPDATE 10-Brent crude jumps, settles up over $3 after tanker attacks3:15:37 PM ETCLX$99.10-0.10(-0.10%)Global Surface Disinfectant Market to Hit US$ 7.5 Bn by 2031, Registering at 7.4% CAGR: Wissen Research3:14:00 PM ETTM$218.30+18.94(+9.50%)ERI’s John Shegerian Describes the Current State of Rare Earth Mineral Recovery at World Remanufacturing Summit in Tokyo3:09:00 PM ETMRVL$135.35-24.56(-15.36%)Marvell Just Dropped 49% in a Month: Is MRVL Stock Hopeless or Ready for a Rebound?3:03:21 PM ETSPCX$123.50-12.33(-9.08%)Bull v. Bear: SPCX Faces Uncertainty as Midterm Results Pressure TSLA Merger3:00:38 PM ETINTC$52.09-6.19(-10.62%)Intel Shares Rise 6% To Intraday High After Key Trading Signal3:00:27 PM ETAMD$408.18-80.51(-16.47%)Advanced Micro Devices vs. Taiwan Semiconductor Manufacturing: The AI Sell-Off Is Exposing a Critical Difference Investors Shouldn't Ignore for 20273:00:02 PM ETHSY$177.43+2.93(+1.68%)Hershey vs. Coca-Cola: Which Consumer Goods Stock Is a Better Buy for 2027?2:51:29 PM ET

ETON · NASDAQ

Eton Pharmaceuticals, Inc.

$57.00 +6.23 (+12.27%)

Company overview

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate synthase deficiency; and Rezipres, a ready-to-use formulation indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$1.6B
Employees
44
Headquarters
Deer Park, IL
Website
etonpharma.com
CEO
Sean E. Brynjelsen
Listed
November 14, 2018
P/E
-1,125.24
Dividend yield
0.00%

Company financials

Revenue
$86.9M
Gross profit
$47.6M
Operating income
$2M
EBITDA
$5.7M
Net income
-$1.5M
EPS
-$0.05
Total assets
$97.7M
Total debt
$12.2M
Gross margin
54.77%
Net margin
-1.70%
Earnings yield
-0.09%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

25.0735.7946.5257.2467.96
ETON 1D NASDAQ O51.76H52.30L49.35C50.72-0.23 (-0.45%)Vol375.32K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London GlobeNewswire
ETONEton Pharmaceuticals, Inc. Press release Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update GlobeNewswire
ETONEton Pharmaceuticals, Inc. Stock news ETON Gears Up to Report Q3 Earnings: What Can Investors Expect? Zacks Investment Research
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic Spasms GlobeNewswire
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026 GlobeNewswire
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film GlobeNewswire
ETONEton Pharmaceuticals, Inc. Stock news Financial Survey: Eton Pharmaceuticals (NASDAQ:ETON) vs. Cronos Group (NASDAQ:CRON) Defense World
ETONEton Pharmaceuticals, Inc. Stock news ETON Stock Surges 108% in Six Months: Here's What You Need to Know Zacks Investment Research
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules GlobeNewswire
ETONEton Pharmaceuticals, Inc. Stock news Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Stock Has Consensus Price Target of $67.50 According to Brokerages Defense World
ETONEton Pharmaceuticals, Inc. Stock news Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE Defense World
ETONEton Pharmaceuticals, Inc. Stock news Jim Cramer: 'You Could Make Some Money With This 5.6% Yield' Benzinga
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference GlobeNewswire
ETONEton Pharmaceuticals, Inc. Stock news Why Eton Pharmaceuticals Is Top of the Class Today The Motley Fool
ETONEton Pharmaceuticals, Inc. Stock news Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These Seeking Alpha
ETONEton Pharmaceuticals, Inc. Stock news Eton Pharmaceuticals, Inc. (ETON) Q2 2026 Earnings Call Transcript Seeking Alpha
ETONEton Pharmaceuticals, Inc. Stock news Eton Pharmaceuticals Q2 Earnings Call Highlights MarketBeat
ETONEton Pharmaceuticals, Inc. Stock news Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates Zacks Investment Research
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results GlobeNewswire
ETONEton Pharmaceuticals, Inc. Press release Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 GlobeNewswire
See more
FAQ

Questions about Eton Pharmaceuticals, Inc.

What does Eton Pharmaceuticals, Inc. do?
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate synthase deficiency; and Rezipres, a ready-to-use formulation indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis.
What is ETON's market cap?
Eton Pharmaceuticals, Inc. (ETON) is a listed stock with a live quote. The latest market cap on this page is $1.6B.
Where is Eton Pharmaceuticals, Inc. headquartered?
Eton Pharmaceuticals, Inc. is headquartered in Deer Park, IL.
How do I get ETON news from the API?
Call GET /v1/news?tickers=ETON. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does ETON news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ETON, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the ETON price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs